Microbiome modulators in the treatment of infectious diseases: insights from clinical trials
Shidong Wang, Chenjuan Wang, Linhua Shen, Mengjin Zhu, Jiannong Wu · 2024
Read Microbiome modulators in the treatment of infectious diseases: insights from clinical trials by Shidong Wang, Chenjuan Wang, Linhua Shen, Mengjin Zhu, Jiannong Wu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11575062.txt.
Description
Shidong Wang and four colleagues present a 2024 research letter taking stock of a fashionable treatment idea: fighting infections by tuning the microbiome. Probiotics, prebiotics, fecal transplants, and engineered living medicines all aim to strengthen barriers, crowd out pathogens, or stir the immune system. The team searched a clinical trials database for this strategy in infectious disease.
They found eight hundred fifty-eight trials meeting their criteria as of September 2024. Trial counts climbed steeply after 2012 and peaked in 2021, and most trials had completed, including many late-phase ones, signaling real clinical momentum. The authors read the landscape as a field moving from curiosity to contenders, and they map where the trials concentrate.
Catalog record
| CREATOR | Shidong Wang, Chenjuan Wang, Linhua Shen, Mengjin Zhu, Jiannong Wu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |